Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma miR-26a-5p is a biomarker for retinal neurodegeneration of early diabetic retinopathy

30 Apr 2021

Abstract excerpt

Upon completion of this activity, participants will: In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Springer Nature. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neuroinflammation and Neurodegeneration Mechanisms
Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33931763
DOI: 10.1038/s41433-021-01393-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma miR-26a-5p is a biomarker for retinal neurodegeneration of early diabetic retinopathyPMID 33931763Read ↗

Advances in the Molecular Pathophysiology and Emerging Therapeutic Strategies for Diabetic RetinopathySemantic proximity Read ↗

A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping.Semantic proximity Read ↗

Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?Semantic proximity Read ↗

Circulating microRNA Biomarkers of Diabetic RetinopathySemantic proximity Read ↗

Diabetic retinopathy: Proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanismsSemantic proximity Read ↗

Advances and Perspectives in Relation to the Molecular Basis of Diabetic Retinopathy—A ReviewSemantic proximity Read ↗

Noncoding RNAs Are Promising Therapeutic Targets for Diabetic Retinopathy: An Updated Review (2017–2022)Semantic proximity Read ↗

Biomarker potential of vitreous microRNA in retinal disease: a meta-analysisSemantic proximity Read ↗

In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathySemantic proximity Read ↗

Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and PyroptosisSemantic proximity Read ↗

Phenotypes and biomarkers of diabetic retinopathy.Semantic proximity Read ↗

Retinal and circulating mi RNA expression patterns in diabetic retinopathy: An in silico and in vivo approachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.